Business News

Brecon Strengthens Board Line-Up

New board line-up at Brecon (L-R) Russell Thomson, Quality Assurance & Regulatory Affairs Director; Steve Kemp, Business Development Director; Andrew Billington, Senior Director of Operations; Peter Belden, Managing Director; Mervyn Newton, Finance & IT Director; Barry Roberts, Head of Human Resources; Sue Miles; Clinical Trials & Customer Services Director

Tuesday 24. November 2009 - Brecon Pharmaceuticals, the leading supplier of commercial packaging and clinical trials supplies services for the pharmaceutical and healthcare sectors, has announced the appointment of Peter Belden as managing director.

Mr Belden previously held the post of senior vice-president, sales and marketing at Brecon’s AmerisourceBergen Packaging Group sister company Anderson Packaging (Rockford, IL). He worked at Anderson for seven years and has extensive experience in the pharmaceutical packaging industry. A graduate of the University of Virginia, Mr Belden also has an MBA from DePaul University.

The appointment further strengthens links between Brecon and its US sister companies and underlines AmerisourceBergen Packaging Group’s commitment to offer a truly global service for the pharmaceutical sector. “I’m delighted to be joining Brecon at such an exciting time,” says Mr Belden. “There is a very strong and deeply experienced team in place and the company’s reputation for quality and customer service is second to none.

“Changing business models in the pharmaceutical industry mean that manufacturers are increasingly looking for full service packaging rather than ad hoc contract packaging. Brecon has made substantial investment in equipment and services to support pharmaceutical products through their entire life cycle, from early phase clinical trials to commercialisation and beyond, such that the company is perfectly positioned to offer exactly what the industry needs. And the ongoing harmonisation of capabilities at AmerisourceBergen Packaging Group companies enables us to extend our reach globally,” affirms Mr Belden.

Simultaneous with Mr Belden’s appointment, Andrew Billington has been promoted to senior director, operations. Mr Billington, who has been with Brecon for 17 years, is currently taking responsibility for the company’s Lean Six Sigma and Operational Excellence initiatives.

Brecon’s offering for the pharmaceutical industry includes phase I-IV clinical trials supplies management, consultative and QP capabilities, full laboratory facilities for analytical and stability testing, pack design and development, and commercial packaging for a wide range of product and pack formats. A highly flexible approach ensures the right level of support is available for every customer, from blockbuster brand-owners through to virtual companies.

“When it comes to getting a new chemical entity to market, every day counts,” says Peter Belden. “No-one understands this better than the team at Brecon and it’s this deep appreciation of the market we serve that will ensure we go on to achieve even greater success in the future.”